Methylene Blue Treatment of Chronic Hepatitis B Virus Infection

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Chronic HBV Infection
Interventions
DRUG

Methylene Blue

"Subjects will be initially treated with an initial dose of 200mg/day for 8 weeks at which point the investigators will assess the effect of the treatment.~Those patients that obtain a complete response will continue their treatment up to a total of 24 weeks with the same dose. Those who do not reach a complete response will be exposed to the next higher dose of 400mg/day for the following 8 weeks and the investigators will then again assess the effect of the treatment.~Those patients that obtain a complete response will continue their treatment up to a total of 24 weeks with the same dose. Those who do not reach a complete response will be exposed to the next higher dose of 600mg/day for the following 8 weeks and the investigators will then assess the effect of the treatment."

Trial Locations (1)

6900

RECRUITING

Epatocentro Ticino, Lugano

All Listed Sponsors
lead

Fondazione Epatocentro Ticino

OTHER

NCT06887036 - Methylene Blue Treatment of Chronic Hepatitis B Virus Infection | Biotech Hunter | Biotech Hunter